Health Matters
Genomic medicine is shaping the future of personalised healthcare, says Learna
News
Jan 7th, 2025

 

Learna highlights the transformative role of genomic medicine in healthcare while equipping clinicians with the skills needed to harness its potential.

Genomic medicine, or the use of a patient’s genetic information to guide healthcare decisions, is changing how we understand, diagnose, and treat disease. Today, healthcare professionals can make tailored treatment decisions in ways that had never been previously possible. The global genomics market is experiencing rapid growth and is projected to reach approximately £79 billion by 2032. Recognising the critical importance of this field, Learna, a leader in online postgraduate medical education, is equipping healthcare professionals with the knowledge they need to take on this transformation.

“The promise of genomic medicine is immense", commented Dr. Anish Kotecha, Head of Medical Education at Learna. "From the identification of genetic predispositions to the provision of treatments for cancer and rare diseases, genomics is allowing us to move towards preventive, not reactive, healthcare. However, to release its full potential, the education and upskilling of clinicians across disciplines should be paramount."

“With genomic data becoming increasingly available, the demand for healthcare professionals able to interpret and apply such information is surging. Of course, most of this calls for a revamp in medical training. Most professionals find it difficult to get such training due to time restraints and busy schedules. Logically, Learna has introduced genomics within its flexible online curriculum, which allows professionals to learn at their own pace.”

Medical education has already benefited tangibly thanks to the integration of genomics. For instance, advancements in pharmacogenomics are allowing doctors to predict patient responses to medications, therefore reducing adverse drug reactions and improving outcomes. Similarly, the ability to identify genetic markers of diseases such as Alzheimer’s or diabetes opens the  avenue to earlier interventions and lifestyle changes that substantially alter the course of these diseases.

“What we're seeing is a notable shift," Dr Kotecha continued. "It's the educators' and institutions' responsibility to prepare the workforce for this different landscape. This isn't the future of genomic medicine; this is today, and it's going to alter the way we look at healthcare.”

Despite its potential, the field is not without its challenges. Concerns over data privacy, equitable access, and the interpretation of complex genetic information highlight the need for robust training and ethical guidelines. Through its commitment to innovation and education, Learna aims to address these challenges head-on, fostering a generation of clinicians who are not only skilled in genomics but also equipped to lead conversations around its ethical and societal implications.

"Genomic medicine brings some fantastic opportunities, but with those come great responsibilities. As educators, we have to prepare healthcare professionals who are ready to use these tools not only effectively, but responsibly too; benefits must be distributed equitably, and the trust of patients has to be upheld."

No comments posted...
Leave a Comment
* Name
* Email (will not be published)
Enter Your Comment
* - Required fields
 
Site Copyright HealthMatters 
Site Created by Point Design & Galatai Ltd.